Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- LEN -2.7%, VTOL -1.2% (guidance), CRMT -0.5%
Other news:
- ZNTL -26.7% (provides update on azenosertib clinical development program)
- NEE -4.9% (to sell $2.0 bln of equity units)
- JELD -4.5% (names new CFO)
- URGN -3.2% (prices $107.5 mln offering consisting of ordinary shares and pre-funded warrants)
- VRE -2.9% (stock offering) PM -2.8% (discloses District of Columbia subpoena)
- GRFS -2.3% (completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group)
- IONS -1.8% (announces expanded licensing agreement with Otsuka (OTSKY) in Asia Pacific for investigational medicine donidalorsen in hereditary angioedema)
- SYRE -1.7% (Announces First Participants Dosed in Phase 1 Trial of SPY001)
- DJT -1.5% (discloses that Truth Social vows to punish short sellers, says streaming service 'moving forward')
- FUN -1.1% (Cedar Fair and and Six Flags Entertainment Corporation (SIX) announce the senior management team that will lead the combined company following the completion of their previously announced merger of equals)
- AZN -1% (provides update on the CAPItello-290 Phase III trial for Truqap plus chemotherapy in advanced or metastatic triple-negative breast cancer)